Mark Dowling (@markrdowling) 's Twitter Profile
Mark Dowling

@markrdowling

Haematology registrar at @PeterMacCC, immunologist @WEHI_Research, ex-quantum physicist and new dad

ID: 53909276

calendar_today05-07-2009 13:27:45

34 Tweet

104 Takipçi

191 Takip Edilen

Dr Heather Williams MBE (@alrightpet) 's Twitter Profile Photo

I can't help but think it should be Prof Sarah Gilbert, the actual expert overseeing the Oxford team who developed the vaccine, whose face features in these announcements. #womeninSTEM

Cell Therapies Pty Ltd (@celltherapies_) 's Twitter Profile Photo

Cell Therapies Pty Ltd has received TGA approval to manufacture Novartis CAR-T therapy, Kymriah® at Peter Mac Cancer Centre in Australia. This will bring faster access to treatment for eligible Australians with life-threatening blood cancers. celltherapies.com.au/tga-approves-c…

Michael Dickinson (@mike_dickinson1) 's Twitter Profile Photo

#ZUMA7 Is positive in favour of #CART #yescarta versus transplant in first high risk relapse of #DLBCL #lymphoma #lymsm. Incredibly exciting news and some actual numbers in the press release! Very exciting. businesswire.com/news/home/2021…

Joshua Casan (@joshcasan) 's Twitter Profile Photo

Thrilled to see our group’s paper out. rdcu.be/cogHo Amongst the first demonstrating the potential for CRISPR-Cas13-based targeting of live SARS-CoV-2. Special congrats to the brilliant Fareh Mohamed. Lucky to be part of this project as my first venture into basic science.

Doherty Institute (@thedohertyinst) 's Twitter Profile Photo

Statement on the Doherty Institute modelling: The Doherty Institute understands how extremely challenging lockdown restrictions are for everyone.

Toby Eyre (@tobyeyre82) 's Twitter Profile Photo

POLARIX PFS subgroup analysis in supplementary of NEJM Well worth a look! IPI 3-5 vs IPI 2 differences fairly striking. #ASH21 #lymsm #DLBCL

POLARIX PFS subgroup analysis in supplementary of <a href="/NEJM/">NEJM</a> Well worth a look!
IPI 3-5 vs IPI 2 differences fairly striking. 
#ASH21 #lymsm #DLBCL
Graham Collins (@graham74gc) 's Twitter Profile Photo

Bishop - Belinda - Tisa-cel v SOC in 2L Agg NHL - Refract or < 12mo 1L, bridging OK - 1 EP: EFS - death or PD/SD at 12 week assessment - 322 random, 33% SOC had ASCT - Median EFS both arms 3mo - 51% crossed to tisa-cel tisa-cel < liso/Axi - or study design issue? #ASH21 #lymsm

Bishop - Belinda
- Tisa-cel v SOC in 2L Agg NHL
- Refract or &lt; 12mo 1L, bridging OK
- 1 EP: EFS - death or PD/SD at 12 week assessment
- 322 random, 33% SOC had ASCT
- Median EFS both arms 3mo
- 51% crossed to tisa-cel
tisa-cel &lt; liso/Axi - or study design issue?
#ASH21 #lymsm
Jordan Gauthier (@drjgauthier) 's Twitter Profile Photo

A fantastic opportunity to join our group Fred Hutch Cancer Center Evan Newell as a Bioinformatics Analyst. social.icims.com/viewjob/pt1639… You will help us analyze high-dimensional proteomic/genomic data from CAR T cell patients (amongst other things!) Please RT! Alexandre Hirayama Krishna R. Juluri, MD, PhD

Dylan O'Donnell 🦋 (@erfmufn) 's Twitter Profile Photo

Physics Quiz! How many Hiroshimas/Megatons of explosive force does it take to get the Tennis off the front page of all major Australian news outlets? (Clue: it's more than 1000 Hiroshimas)

Leukaemia Foundation (@leukaemiaaus) 's Twitter Profile Photo

Each year we join forces with 伊藤佑愛 & Snowdome Foundation to identify & fund new translational research projects. Congratulations Assoc. Professor Jane Oliaro Peter Mac Research and Professor Richard Lock Childrens Cancer Institute! Learn more: rebrand.ly/translational-…

Each year we join forces with <a href="/LLSusa/">伊藤佑愛</a> &amp; <a href="/SnowdomeAU/">Snowdome Foundation</a> to identify &amp; fund new translational research projects.
Congratulations Assoc. Professor Jane Oliaro <a href="/PeterMacRes/">Peter Mac Research</a> and Professor Richard Lock <a href="/KidsCancerInst/">Childrens Cancer Institute</a>!
Learn more: rebrand.ly/translational-…
Jordan Gauthier (@drjgauthier) 's Twitter Profile Photo

Surprised this went through peer-review unnoticed... What is the issue with the proposed analysis shown in the plot? Very exciting data nonetheless! ncbi.nlm.nih.gov/pmc/articles/P… Journal of Clinical Oncology

Surprised this went through peer-review unnoticed...
What is the issue with the proposed analysis shown in the plot?
Very exciting data nonetheless!
ncbi.nlm.nih.gov/pmc/articles/P…
<a href="/JCO_ASCO/">Journal of Clinical Oncology</a>
NEJM (@nejm) 's Twitter Profile Photo

Late breaking at #ASCO23: In the phase 3 ZUMA-7 trial, patients with relapsed or refractory large B-cell lymphoma who received axi-cel (CD19-specific CAR T cells) had a 27.4% lower risk of death than patients who received standard therapy. Full trial results:

Michael Dickinson (@mike_dickinson1) 's Twitter Profile Photo

Zuma7 shows that, in spite of cross over in >50%, there is an OVERALL SURVIVAL BENEFIT for CAR-T (Axi-Cel) versus chemo+transplant for #DLBCL #lymphoma - the NEJM Paper is online! bit.ly/43Fpxmn #lymsm Great to have been a part of this practice-changing trial.

Zuma7 shows that, in spite of cross over in &gt;50%, there is an OVERALL SURVIVAL BENEFIT for CAR-T (Axi-Cel) versus chemo+transplant for #DLBCL #lymphoma - the NEJM Paper is  online! bit.ly/43Fpxmn  #lymsm Great to have been a part of this practice-changing trial.
Dr T. Comeau , MD (@sctnb) 's Twitter Profile Photo

Immune Effector Cell-Associated Hematotoxicity (ICAHT): EHA/EBMT Consensus Grading and Best Practice Recommendations | Blood | American Society of Hematology ashpublications.org/blood/article/…

Michael Dickinson (@mike_dickinson1) 's Twitter Profile Photo

#CART and fixed #ibrutinib for #Mantle cell #lymphoma in @bloodjournal. More evidence that immunotherapy may help with high-risk molecular subtypes. Congrats to @adrianminson for driving this lightning-fast @petermacres IIT as part of his PHD! #lymsm bit.ly/3Q73904

#CART and fixed #ibrutinib for #Mantle cell #lymphoma in @bloodjournal. More evidence that immunotherapy may help with high-risk molecular subtypes. Congrats to @adrianminson for driving this lightning-fast @petermacres IIT as part of his PHD! #lymsm bit.ly/3Q73904
Pietro Di Ciaccio (@prpdiciaccio) 's Twitter Profile Photo

Important work regarding high prevalence of BCMA expression in PBL. There is no consensus in the treatment of RR PBL and anti BCMA therapies are intriguing. Interestingly the two patients exposed to CD19 directed CART in this small series died. #lymsm